Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Takeda Development Center Americas, Inc.

Takeda Development Center Americas, Inc. Recalls

All product recalls associated with Takeda Development Center Americas, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Nov 2018

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–2 of 2 recalls

Amitiza Capsules (Takeda) – Impurity Level Elevated (2018)

Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.

Class IIILow

FDANov 6, 2018Nationwide• Takeda Development Center Americas, Inc.

Actoplus met XR Tablets (Takeda) – Defective Delivery (2018)

Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Class IIModerate

FDASep 10, 2018AR, LA, MS +6 more• Takeda Development Center Americas, Inc.